Pharmacoeconomics of the dosage of insulin vs rosiglitazone after failing of metformin in monotherapy in diabetes mellitus of tyspe 2

Abstract

Aim of this study is pharmacoeconomics of the dosage of insulin vs rosiglitazone after failing of metformin in monotherapy in diabetes mellitus of tyspe 2

Keywords

• Pharmacoeconomics